Related Experiment Video
Updated: Jun 30, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Optimizing protected PCI strategies in the setting of chronic kidney disease and advanced coronary artery disease: a
Mario Iannaccone1, Jerzy Sacha2,3, María Monteagudo-Vela4
1Department of Cardiology, Turin Nord Emergency Hospital, Piazza Donatori di Sangue 3, 10100 Torino TO, Italy.
Insights
Mechanical circulatory support (MCS) with a microaxial flow pump (mAFP) can improve procedural safety during percutaneous coronary intervention (PCI) for high-risk patients. This approach helps manage complex coronary artery disease (CAD) and reduces adverse outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Patients with chronic coronary artery disease (CAD) and severely reduced left ventricular ejection fraction (LVEF) are high-risk for percutaneous coronary intervention (PCI).
- Complex coronary anatomy, comorbidities like chronic kidney disease, and impaired cardiac reserve increase procedural risks, including hemodynamic instability and acute kidney injury (AKI).
Purpose of the Study:
- To highlight the role of mechanical circulatory support (MCS) in enhancing procedural safety for high-risk patients undergoing PCI.
- To demonstrate the utility of a microaxial flow pump (mAFP) in managing complex CAD in a vulnerable population.
Main Methods:
- A case presentation of an elderly male patient with multivessel CAD, reduced LVEF, and multiple comorbidities.
- Utilized Impella™ (a type of mAFP) for mechanical circulatory support during percutaneous coronary intervention (PCI).
Main Results:
- Impella™-supported PCI provided left ventricular unloading and augmented cardiac output, optimizing procedural safety.
- The use of MCS potentially mitigated the risk of AKI and expanded revascularization options for this high-risk patient.
Conclusions:
- Mechanical circulatory support (MCS) is a valuable strategy for managing high-risk patients with complex CAD undergoing PCI.
- Impella™-assisted PCI can improve outcomes and safety in patients with severely reduced LVEF and multiple comorbidities.
Abstract:
Patients with chronic coronary artery disease (CAD) and severely reduced left ventricular ejection fraction (LVEF) represent a particularly high-risk population often deemed unsuitable for conventional revascularization strategies. Procedural challenges arise from complex coronary anatomy, impaired cardiac reserve, and frequent comorbidities, such as frailty and chronic kidney disease, all of which predispose patients to haemodynamic instability and adverse outcomes during percutaneous coronary intervention (PCI). The use of mechanical circulatory support (MCS) devices, such as a microaxial flow pump (mAFP), has emerged as an important strategy to mitigate these risks by providing continuous left ventricular unloading and augmenting cardiac output. Moreover, improved perfusion may attenuate the risk of acute kidney injury (AKI), a major determinant of post-PCI morbidity and mortality. Herein, we present a case of Impella™-supported PCI in an elderly male patient with multivessel CAD, markedly reduced LVEF, chronic kidney disease, and multiple comorbidities, highlighting the role of MCS in optimizing procedural safety and expanding revascularization options for this vulnerable patient population.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations